Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Multiple Cancer Types
This is an open label Phase 1, First in Human trial of TST001, a recombinant humanized anti-Claudin 18.2 (CLDN18.2) IgG1 monoclonal antibody. It is being tested against advanced and / or metastatic solid tumors including gastric, gastroesophageal junction, pancreatic, colon and lung cancers.
Miscellaneous, Phase I